BIO's new CEO takes a pa­tri­ot­ic piv­ot to win back Con­gress, push­ing in­dus­try to re­think Chi­na re­la­tion­ship

12 months ago
China
In Focus

Os­car stakes its fu­ture on com­pa­nies dump­ing work­er health ben­e­fits

12 months ago
Financing
Health Tech

New obe­si­ty biotech Syn­tis Bio launch­es with ear­ly-stage al­ter­na­tive to GLP-1s

12 months ago
Financing

Ex­clu­sive: Aux­il­ius rais­es $10M to help biotechs man­age clin­i­cal tri­al fi­nances

12 months ago
Health Tech

Ipsen and Gen­fit se­cure FDA thumbs up for rare liv­er dis­ease as­set

12 months ago
Pharma
FDA+

FDA ad­vi­sors back Lil­ly’s Alzheimer’s drug, set­ting stage for ap­proval af­ter de­lay

12 months ago
Pharma
FDA+

Paxlovid did not beat place­bo in Stan­ford-led long Covid study

12 months ago
R&D
Pharma

GSK stands by Or­ange Book patents that FTC has asked to re­scind

12 months ago
FDA+
Law

Ky­owa Kirin in­vests $530M in first man­u­fac­tur­ing site in North Amer­i­ca

12 months ago
R&D
Manufacturing

FDA es­tab­lish­es new meet­ing type to ad­vise on drug safe­ty tech­nol­o­gy

12 months ago
Pharma
FDA+

Teladoc names in­sur­ance ex­ec­u­tive as new CEO

12 months ago
People
Health Tech

EU launch­es two ad­vice pi­lots for clin­i­cal tri­al ap­pli­ca­tions as part of R&D push

12 months ago
Pharma

Oculis touts Phase 2 re­sults in dry eye dis­ease, but most da­ta aren't sta­tis­ti­cal­ly sig­nif­i­cant

12 months ago
R&D

Skye's stock sinks fol­low­ing eye dis­ease fail­ure as com­pa­ny shifts fo­cus to obe­si­ty

12 months ago
R&D

Sh­iono­gi inks deal for pre­clin­i­cal hear­ing loss ther­a­pies; Alvotech’s re­fi­nanc­ing pact

12 months ago
News Briefing

Alu­mis files for IPO ahead of Phase 3 stud­ies for sec­ond-gen TYK2 in­hibitor

12 months ago
Financing

GSK nix­es Spring­Works li­cens­ing deal fo­cused on Blenrep-Og­siveo for blood can­cer

12 months ago
Deals

Mod­er­na’s Covid and flu com­bo vac­cine suc­ceeds in Phase 3 study

12 months ago
R&D

GSK wins ex­pand­ed FDA ap­proval for RSV shot in at-risk adults ages 50 to 59

12 months ago
Pharma
FDA+

UK medtech rais­es $100M for two-in-one uri­nary in­con­ti­nence treat­ment

12 months ago
Financing

FDA rais­es ques­tions about Lil­ly's Alzheimer's drug; Ad­comm votes against MD­MA ther­a­py; In­side Wal­mart Health's ...

12 months ago
Weekly

Fed­er­al judge dis­miss­es an­titrust claims brought against Bris­tol My­ers by in­sur­ers

12 months ago
Pharma
Law

FDA green­lights Geron’s ime­tel­stat to treat ane­mia in cer­tain can­cer pa­tients

12 months ago
Pharma
FDA+

Ital­ian an­titrust agency in­ves­ti­gates No­var­tis, Bio­gen and oth­ers over Lu­cen­tis biosim­i­lar

12 months ago
Pharma
FDA+
First page Previous page 145146147148149150151 Next page Last page
A service from the Financial Times